Does intermittent hypoxia from sleep-disordered breathing cause secondary erythrocytosis?

Sleep-disordered breathing (SDB), particularly obstructive sleep apnea, is a well-established driver of secondary erythrocytosis. This process is initiated by recurrent nocturnal oxygen desaturations that trigger adaptive physiological responses to maintain systemic oxygen delivery.

Clinical and effectiveness evidence

In clinical practice, SDB is recognized as a significant cause of elevated red blood cell parameters. Research demonstrates that while only a small percentage of all SDB patients develop clinical polycythemia, the risk increases dramatically with disease severity.

• Prevalence: In patients with severe OSA, the prevalence of secondary erythrocytosis is approximately 6%, compared to roughly 2% in the general OSA population.
• Diagnostic link: Up to 29% of patients referred for unexplained erythrocytosis are subsequently diagnosed with OSA.
• Treatment response: Continuous Positive Airway Pressure (CPAP) therapy provides strong evidence for causality; clinical studies show mean reductions in hemoglobin of approximately 3.76 g/L and hematocrit by 1.1% following effective treatment of intermittent hypoxia.

Mechanistic explanations

The transition from respiratory events to increased hematocrit is mediated by the Hypoxia-Inducible Factor (HIF) pathway:

• HIF Stabilization: During periods of intermittent hypoxia, the degradation of the HIF-α subunit is inhibited. This allows HIF-2α (the primary regulator of erythropoiesis) to translocate to the nucleus.
• Gene Activation: HIF binds to the Hypoxia Response Elements (HRE) on the erythropoietin (EPO) gene promoter in the kidneys, stimulating de novo EPO synthesis.
• Erythropoiesis: Elevated circulating EPO travels to the bone marrow, where it binds to receptors on erythroid progenitor cells, preventing their apoptosis and accelerating their maturation into red blood cells.

Clinical implications

For a 47-year-old male, elevated hemoglobin or hematocrit levels should prompt a clinical evaluation for SDB, especially if other symptoms like snoring or daytime somnolence are present.

• Differentiation: SDB-induced erythrocytosis is categorized as "secondary" because it is a response to an external stimulus (hypoxia), distinguishing it from primary polycythemia vera (which involves JAK2 mutations and low EPO).
• Complications: Increased hematocrit can increase blood viscosity, potentially compounding the cardiovascular risks already associated with sleep apnea.

Bottom line

Intermittent hypoxia from sleep-disordered breathing directly stimulates the HIF-EPO axis, leading to increased hemoglobin and hematocrit. This secondary erythrocytosis is a physiological adaptation to nocturnal oxygen desaturation and typically resolves with appropriate airway management.